Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis

This publication has 20 references indexed in Scilit:

• Overcoming Economic Barriers To The Optimal Use Of Vaccines
  Health Affairs, 2005
• Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
  The Lancet, 2005
• Immunization, equity, and human rights
  American Journal of Preventive Medicine, 2004
• A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection
  New England Journal of Medicine, 2003
• Estimates of world-wide distribution of child deaths from acute respiratory infections
  Published by Elsevier ,2002
• Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
  New England Journal of Medicine, 2001
• Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
  The Pediatric Infectious Disease Journal, 2000
• Policy analysis of the use of hepatitis B,Haemophilus influenzae type b-,Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules
  Health Economics, 2000
• Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach
  Vaccine, 1995
• Etiology of severe pneumonia in children in developing countries
  The Pediatric Infectious Disease Journal, 1986